| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 10/grams
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Rimonabant is a cannabinod receptor (CB1) antagonist, blocking the brain cannabinod receptor to decrease appetite
and cravings. That reduces a person's weight while people quit nicotine dependence on cigarettes in order to achieve a smoking
cessation effect.
COA
| Test Items | Specification | Test Results |
| Description | White crystalline powder | White crystalline powder |
| Identification | IR, UV conform | Conforms |
| Loss on drying | ≤0.5ml | 0.21ml |
| Residue on ignition | Not more than 0.2% | 0.06ml |
| Iron | Not more than 0.005% | 0.0018% |
| Heavy metals | Not more than 0.001% | 0.0006% |
| Related substances | Total: Not more than 1.0% Individual: Not more than 0.5% |
0.32% 0.14% |
| E-isomer | Not more than 0.3% | 0.19% |
| Organic volatile impurities | Conforms | Conforms |
| Assay | 99.0~101.0% | 99.51% |
| Conclusion | Conforms with USP30 | |
Rimonabant is from the class of medicines called cannabinod receptor antagonists. This drug makes it possible for you to handle dieting easier allowing you to lose excess weight if you have been diagnosed with obesity. This medicine works by selectively blocking certain receptors in the brain and other organs that control metabolism, including the liver, gastrointestinal tract, and adipose tissue. In addition to the beneficial effects of reducing food cravings, this drug has been demonstrated to increase the levels of good cholesterol (HDL) and decrease the levels of bad cholesterol (triglycerides).
According to the clinical studies of this medicine about a third of people who took rimonabant lost 10% of their body weight in the first two years of the treatment, and what's even more important - were able to maintain the result during this time.
){kind=link}